Abstract
A 7-year-old boy developed acute, severe hypercalcaemia following the partial excision of a cerebellar medulloblastoma. The serum calcium level was extremely high (19.8 mg/100 ml), but a skeletal survey revealed no apparent bone metastatic lesions; such lesions were only detected by X-ray 3 weeks after the onset of hypercalcaemia. Hypercalcaemia was promptly resolved by intravenous mithramycin administration, before which the serum parathyroid hormone level, 1,25-(OH)2-vitamin D level and the nephrogenous cyclic AMP level were low. However the relation between serum calcium levels and urinary calcium excretions indicated that renal calcium reabsorption was increased in association with hypercalcaemia, suggesting that a parathyroid hormone-like effect was operative on the renal tubules. It is possible that a combination of increased bone resorption by metastatic tumour cells and renal tubular handling of calcium presumably mediated by tumour-produced humoral factors was responsible for the acute development of severe hypercalcaemia in this patient with medulloblastoma.
Similar content being viewed by others
Abbreviations
- PTH:
-
parathyroid hormone
- HHM:
-
humoral hypercalcaemia of malignancy
References
Arisaka O, Arisaka M, Yabuta K, Shimizu T, Toyono K (1985) Primary hyperparathyroidism: case report and management. Clin Pediatr 24:347–350
Atkins D, Martin TJ (1977) Rat osteosarcogenic sarcoma cells: effects of some prostaglandins, their metabolites and analogues on cyclic AMP production. Prostaglandins 13:861–871
Campbell AN, Chan HSL, Becker LE, Daneman A, Park TS, Hoffman HJ (1984) Extracranial metastases in childhood primary intracranial tumors. A report of 21 cases and review of the literature. Cancer 53:974–981
Einhorn LH, Donohue J (1977) Cis-diamminedichloroplatinum, vincristine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293–298
Gepes MT, D'Angio GJ (1960) Extracranial metastases from central nervous system tumors in children and adolescents. Radiology 87:55–63
Kiang DT, Loken MK, Kennedt BJ (1979) Mechanism of the hypocalcemic effect of mithramycin. J Clin Endocrinol Metab 48:341–344
Klenman GM, Hochberg FH, Richardson EP (1981) Systemic metastases from medulloblastoma: report of two cases and review of the literature. Cancer 48:2296–2309
Lassman LP (1976) Diagnosis and treatment of skeletal metastases from cerebellar medulloblastoma. Childs Brain 2: 38–45
Mundy GR (1985) Pathogenesis of hypercalcaemia of malignancy. Clin Endocrinol 23:705–714
Mundy GR, Martin TJ (1982) Hypercalcemia of malignancy — pathogenesis and treatment. Metabolism 31:1247–1277
Nordin BE, Peacock M (1969) Role of kidney in regulation of plasma-calcium. Lance II:1280–1282
Ralston SH, Folgeman I, Gardner MD, Dryburgh FJ, Boyle IT (1984) Hypercalcemia of malignancy: evidence for a non-PTH humoral agent with an effect of renal tubular handling of calcium. Clin Sci 66:187–191
Ralston SH, Gardner MD, Dryburgh FJ, Jenkins AS, Cowan RA, Boyle IT (1985) Comparison of aminohydroxypropylidene diphosphate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcemia. Lancet II:907–910
Stewart AF, Horst MD, Deftos LJ, Cadman EC, Lang R, Broadus AE (1980) Biochemical evaluation of patients with cancer-associated hypercalcemia. Evidence for humoral and non-humoral group. N Engl J Med 303:1377–1383
Tamura M, Kawafuji J, Ishida Y, Hori S, Fukamachi A, Wakao T (1980) Extracranial metastases in cerebellar medulloblastoma. Report of two cases and review of the literature. Neurol Med Chir (Tokyo) 20:257–264
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arisaka, O., Obinata, K., Yabuta, K. et al. Hypercalcaemia in cerebellar medulloblastoma: pathogenesis of solid tumour-associated hypercalcaemia. Eur J Pediatr 146, 434–436 (1987). https://doi.org/10.1007/BF00444958
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00444958